Financials Shanghai Xuerong Biotechnology Co.,Ltd.

Equities

300511

CNE100002706

Fishing & Farming

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
3.45 CNY +1.77% Intraday chart for Shanghai Xuerong Biotechnology Co.,Ltd. +8.15% -35.51%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,592 2,906 5,768 3,350 3,245 2,668
Enterprise Value (EV) 1 3,979 4,107 6,941 5,014 4,355 4,653
P/E ratio 17.1 x 13.3 x 22.9 x -10.5 x -10.9 x -14.1 x
Yield 2.01% 1.72% 0.92% - - -
Capitalization / Revenue 1.4 x 1.48 x 2.62 x 1.62 x 1.4 x 1.04 x
EV / Revenue 2.15 x 2.09 x 3.15 x 2.43 x 1.88 x 1.81 x
EV / EBITDA 10.6 x 7.41 x 11.8 x 27.8 x 11.1 x 16.7 x
EV / FCF -11.8 x 32 x -98.6 x -7.65 x -68.2 x -10.4 x
FCF Yield -8.5% 3.13% -1.01% -13.1% -1.47% -9.58%
Price to Book 1.65 x 1.67 x 2.79 x 2 x 1.86 x 1.73 x
Nbr of stocks (in thousands) 434,245 429,240 442,030 441,923 503,044 498,781
Reference price 2 5.970 6.770 13.05 7.580 6.450 5.350
Announcement Date 4/24/19 4/24/20 4/9/21 4/26/22 4/25/23 4/25/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,847 1,965 2,202 2,063 2,320 2,565
EBITDA 1 375.2 554.1 588.5 180.3 392.6 279.4
EBIT 1 117.6 270.8 266.2 -131.4 53.48 -41.8
Operating Margin 6.37% 13.78% 12.09% -6.37% 2.3% -1.63%
Earnings before Tax (EBT) 1 141.9 208.1 221.8 -353 -380.5 -192.1
Net income 1 151.5 220.3 247.2 -308.9 -287.2 -188.1
Net margin 8.2% 11.22% 11.23% -14.97% -12.38% -7.33%
EPS 2 0.3500 0.5100 0.5700 -0.7200 -0.5900 -0.3800
Free Cash Flow 1 -338.1 128.5 -70.42 -655.7 -63.88 -445.8
FCF margin -18.31% 6.54% -3.2% -31.78% -2.75% -17.38%
FCF Conversion (EBITDA) - 23.19% - - - -
FCF Conversion (Net income) - 58.31% - - - -
Dividend per Share 2 0.1200 0.1166 0.1200 - - -
Announcement Date 4/24/19 4/24/20 4/9/21 4/26/22 4/25/23 4/25/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3
Net sales 1 - 532.4 568.6
EBITDA - - -
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income 222.7 - -
Net margin - - -
EPS 2 0.4500 -0.3700 -0.3400
Dividend per Share - - -
Announcement Date 4/25/23 8/29/23 10/27/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1,386 1,201 1,172 1,664 1,111 1,985
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.696 x 2.167 x 1.992 x 9.229 x 2.829 x 7.104 x
Free Cash Flow 1 -338 128 -70.4 -656 -63.9 -446
ROE (net income / shareholders' equity) 8.36% 12.6% 12% -19% -24% -12.6%
ROA (Net income/ Total Assets) 1.9% 4.38% 3.96% -1.85% 0.79% -0.6%
Assets 1 7,967 5,035 6,246 16,741 -36,134 31,224
Book Value Per Share 2 3.620 4.050 4.670 3.780 3.470 3.090
Cash Flow per Share 2 0.8800 0.6700 1.750 0.7700 0.7200 0.5000
Capex 1 442 312 483 640 319 1,097
Capex / Sales 23.95% 15.9% 21.92% 31.02% 13.77% 42.77%
Announcement Date 4/24/19 4/24/20 4/9/21 4/26/22 4/25/23 4/25/24
1CNY in Million2CNY
Estimates
  1. Stock Market
  2. Equities
  3. 300511 Stock
  4. Financials Shanghai Xuerong Biotechnology Co.,Ltd.